To investigate the specific effects of SPRR2C, we stimulated human immortalized keratinocytes (HaCaT cells) with IL-22 (100 ng/ml) for 24 h to mimic the in vitro pathological changes in psoriasis, conducted SPRR2C knockdown in HaCaT cells, and then examined related indexes. The gene discussed is IL22; the disease is psoriasis.